ANSWERS
NEWEST UPDATE LEARNING TEST LATEST
VERSION 2025 2026 RATED 100%
A patient currently undergoing concurrent chemotherapy/radiation
M M M M M
treatment for glottic squamous cell carcinoma is admitted to the rehab
M M M M M M M M M M M
unit you oversee for management of intractable nausea, vomiting, and
M M M M M M M M M M
dehydration. Admission CBC showed WBC 1.3, Hgb 7.5, PLT 45, ANC 0.8.
M M M M M M M M M M M M
Which of the following conditions is this patient at risk for?
M M M M M M M M M M M
A. Macrocytic anemia due to B12 deficiency
M M M M M
B. Iron deficiency anemia due to chronic blood loss
M M M M M M M
C. Microcytic anemia due to chronic kidney disease
M M M M M M
D. Aplastic anemia due to bone marrow suppression
M M M M M M
D
M
,Your patient presents to the urgent care clinic with a swollen exudative
M M M M M M M M M M M
pharynx, profound fatigue, and a very tender left upper quadrant
M M M M M M M M M M
abdomen. What is the most likely diagnosis?
M M M M M M M
A. Strep pharyngitisM
B. Tonsillitis
C. Epstein Barr virus (EBV) M M M
D. Pancreatitis
C
M
Which of the following best characterizes presbycusis in the older adult?
M M M M M M M M M M
A. Bilateral low-frequency sensorineural hearing loss
M M M M
B. Bilateral high-frequency sensorineural hearing loss
M M M M
C. Unilateral high-frequency sensorineural hearing loss
M M M M
D. Unilateral low-frequency sensorineural hearing loss
M M M M
B
M
A 35-year-old woman presents with allergic rhinitis, experiencing
M M M M M M M
significant nasal congestion, sneezing, and itchy eyes. She has tried over-
M M M M M M M M M M M
the-counter antihistamines with limited relief. What is the most
M M M M M M M M M
appropriate next step in management?
M M M M M
A. Oral decongestants
M
B. Nasal saline irrigation
M M
C. Intranasal corticosteroids M
D. Referral to an allergist for immunotherapy
M M M M M
C
M
A patient currently undergoing concurrent chemotherapy/radiation
M M M M M
treatment for glottic squamous cell carcinoma is admitted to the rehab
M M M M M M M M M M M
,unit you oversee for management of intractable nausea, vomiting, and
M M M M M M M M M
dehydration. Admission CBC showed WBC 1.3, Hgb 7.5, PLT 45, ANC 0.8.
M M M M M M M M M M M M
Which of the following conditions is this patient at risk for?
M M M M M M M M M M M
A. Iron deficiency anemia due to chronic blood loss
M M M M M M M
B. Microcytic anemia due to chronic kidney disease
M M M M M M
C. Macrocytic anemia due to B12 deficiency M M M M M
D. Aplastic anemia due to bone marrow suppression
M M M M M M
D
M
A 78 y.o. M patient reports chronic infections, bruising, fatigue, SOB, and
M M M M M M M M M M M
fevers. He has a history of rectal adenocarcinoma and completed
M M M M M M M M M M
concurrent chemotherapy/radiation earlier this year. His CBC shows Hgb
M M M M M M M M M
7.5, PLT 88, WBC 1.2, ANC 0.8, and peripheral smear shows dysplasia.
M M M M M M M M M M M M
What additional work-up would you anticipate for this patient?
M M M M M M M M
A. Colonoscopy and fecal occult blood test M M M M M
B. Bone marrow biopsy and flow cytometry
M M M M M
C. No additional work-up is required, these are expected sequela of his
M M M M M M M M M M
oncologic treatment
M M
D. Repeat CBC/CMP/peripheral smear in eight weeks
M M M M M
B
M
Progression to Acute Myelogenous Leukemia (AML) is a risk for untreated
M M M M M M M M M M
or poorly responsive:
M M M
A. Pancytopenia
B. Aplastic anemia M
C. Macrocytic anemia M
D. Myelodysplastic syndrome M
, D
Treatment for symptomatic aplastic anemia includes all the following
M M M M M M M M
except:
M
A. Bone marrow transplant
M M
B. PRBC/Platelet/WBC transfusions M
C. Prophylactic antibiotics M
D. Removal of bone marrow stimulants
M M M M
D
M
A patient diagnosed with iron deficiency anemia requires iron
M M M M M M M M
supplementation. Which of the following treatments would likely be
M M M M M M M M M
ineffective?
M
A. Ferrous sulfate 325 mg PO BID for a 43 y.o. F s/p gastric bypass 2 years
M M M M M M M M M M M M M M M
ago
M
B. Iron sucrose 200 mg IV infusion weekly x 8 weeks in a 26 y.o. F at 34
M M M M M M M M M M M M M M M M
weeks of pregnancy
M M M
C. Ferrous sulfate 325 mg PO TID for a 25 y.o. F with menorrhagia
M M M M M M M M M M M M
D. Ferrous sulfate 325 mg PO BID for a 63 y.o. M with ulcerative colitis A
M M M M M M M M M M M M M M
Which of the following is not a common mechanism of neutrophil
M M M M M M M M M M
expenditure and resultant neutropenia?
M M M M
A. Decreased neutrophil production in the bone marrow
M M M M M M
B. Redistribution of neutrophils to the spleen or vascular endothelium
M M M M M M M M
C. Loss of circulating neutrophils in acute blood loss
M M M M M M M
D. Immune destruction M
C
M